Skip to main content
. 2014 Jul 9;49(6):1964–1979. doi: 10.1111/1475-6773.12201

Figure 2.

Figure 2

Relapse Rates among MassHealth Members with Opioid Use Disorders Who Started a Buprenorphine Treatment Episode in 2007 (N = 2,049) (1/1/07 – 12/30/08) Note. Includes 2,049 MassHealth members who started a buprenorphine treatment episode at any time during 2007. The number of members in treatment each month ranged from 188 (in January 07) to 1,051(in November 07). Members were followed from the start of treatment in 2007 through the end of the treatment episode, until 12/31/08. Dose groups were based on the member's highest buprenorphine dose in 2007 and were defined as follows: Low (≤16 mg), Medium (>16 mg and ≤24 mg), and High (>24 mg).